Continuous intra-arterial chemotherapy with 5-fluorouracil and cisplatin for locally advanced anaplastic carcinoma of the pancreas

被引:5
|
作者
Benedix, Frank [1 ]
Schmidt, Cornelia [1 ]
Schulz, Hans-Ulrich [1 ]
Lippert, Hans [1 ]
Meyer, Frank [1 ]
Pech, Maciej [2 ]
机构
[1] Univ Hosp Magdeburg, Dept Surg, D-39120 Magdeburg, Germany
[2] Univ Hosp Magdeburg, Dept Radiol, D-39120 Magdeburg, Germany
关键词
Splenic Artery; Anaplastic Carcinoma; Celiac Plexus; Elevated White Blood Cell Count; Celiac Plexus Block;
D O I
10.1007/s00384-008-0441-0
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:729 / 731
页数:3
相关论文
共 50 条
  • [1] Continuous intra-arterial chemotherapy with 5-fluorouracil and cisplatin for locally advanced anaplastic carcinoma of the pancreas
    Frank Benedix
    Cornelia Schmidt
    Hans-Ulrich Schulz
    Hans Lippert
    Frank Meyer
    Maciej Pech
    International Journal of Colorectal Disease, 2008, 23 : 729 - 731
  • [2] Combined intra-arterial 5-fluorouracil and cisplatin chemotherapy prolong Survivals in advanced hepatocellular carcinoma
    Nagai, Hidenari
    Kanayama, Masahiro
    Yoshizawa, Kaoru
    Higami, Katsuya
    Fujita, Yasuko
    Watanabe, Keita
    Momiyama, Kouichi
    Ikoma, Akiko
    Okano, Naoki
    Ikehara, Takashi
    Matsumaru, Katsuhiko
    Watanabe, Manabu
    Iida, Kazunari
    Ishii, Koji
    Sumino, Yasukiyo
    Miki, Kazumasa
    GASTROENTEROLOGY, 2006, 130 (04) : A778 - A778
  • [3] Intra-arterial chemotherapy for locally advanced carcinoma of the pancreas (LAPC)
    Cantore, M
    Fiorentini, G
    Molani, L
    Cavazzini, G
    Aitini, E
    Rabbi, C
    Mambrini, A
    Zamagni, D
    Amadori, M
    Morandi, C
    Grassi, E
    Lusenti, A
    Smerieri, F
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 552 - 552
  • [4] Intra-arterial infusion chemotherapy with 5-fluorouracil and cisplatin in advanced pancreatic cancer - A feasibility study
    Sasada, Tetsuro
    Denno, Ryusuke
    Tanaka, Tomoharu
    Kanai, Michiyuki
    Mizukami, Yo
    Kohno, Shigene
    Takabayashi, Arimichi
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008, 31 (01): : 71 - 78
  • [5] Effect of low dose 5-fluorouracil and cisplatin intra-arterial infusion chemotherapy in advanced hepatocellular carcinoma with decompensated cirrhosis
    Cheong, J. Y.
    Cho, S. W.
    Lim, T. Y.
    Lee, K. M.
    Hahm, K. B.
    Kim, J. H.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S99 - S99
  • [6] INTRA-ARTERIAL CHEMOTHERAPY WITH CISPLATIN AND 5-FLUOROURACIL IN CASES OF EPIDERMOID BUCCOPHARYNGEAL CARCINOMA - A CLINICAL AND PHARMACOKINETIC STUDY
    SANTINI, J
    MILANO, G
    THYSS, A
    RENEE, M
    VALLICIONI, J
    DEMARD, F
    BULLETIN DU CANCER, 1988, 75 (07) : 633 - 634
  • [7] A Phase I/II trial of continuous hepatic intra-arterial infusion of 5-fluorouracil, mitoxantrone and cisplatin for advanced hepatocellular carcinoma
    Ikeda, Masafumi
    Okusaka, Takuji
    Sato, Yozo
    Furuse, Junji
    Mitsunaga, Shuichi
    Ueno, Hideki
    Morizane, Chigusa
    Inaba, Yoshitaka
    Kobayashi, Tatsushi
    Arai, Yasuaki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2017, 47 (06) : 512 - 519
  • [8] Continuous intra-arterial chemotherapy for downstaging locally advanced oral commissure carcinoma
    Wu, Chih-Fung
    Chang, Kao-Ping
    Huang, Chih-Jen
    Chen, Chun-Ming
    Chen, Ching-Yi
    Lin, Chen-Lung Steve
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2014, 36 (07): : 1027 - 1033
  • [9] COMBINATION INTRA-ARTERIAL 5-FLUOROURACIL AND RADIATION-THERAPY FOR UNRESECTABLE CARCINOMA OF PANCREAS
    WILEY, AL
    DAVIS, TE
    RAMIREZ, G
    WIRTANEN, GW
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 314 - 314
  • [10] A phase II study of intra-arterial chemotherapy of 5-fluorouracil, cisplatin, and mitomycin C for advanced nonresectable gastric cancer
    Li, Maoquan
    Zhang, Jiaxing
    Wang, Daoyuan
    Zhong, Baoliang
    Tucker, Steven
    Lu, Chenhui
    Cheng, Jie
    Ca, Chuanwu
    Xu, Jiahua
    Xu, Jichong
    Pan, Hui
    ANTI-CANCER DRUGS, 2009, 20 (10) : 941 - 945